Tylvalosin, a new generation of macrolides, is derived from tylosin. Through a series of chemical reactions, including acetylation, isovalerylation, and alcoholysis, it is synthesized into acetylisovaleryl tylosin, commonly known as tylosin. Its most common commercial form is acetylisovaleryl tylosin tartrate.
Tylvalosin not only has a broad antimicrobial spectrum and significant antimicrobial efficacy, it can effectively address the three major challenges facing pig farming: blue ear disease, mycoplasma infection, and ileitis. It also demonstrates excellent efficacy against other common bacterial diseases.
